Characteristics and Management of Uncontrolled Gout Prior to Pegloticase Therapy: A 2-year Claims Analysis
Abstract Objective Gout is a progressive form of arthritis that causes significant pain and disability. Patients with treatment-refractory (or uncontrolled) gout experience a higher prevalence and severity of comorbidities than those whose gout is controlled. Pegloticase is a recombinant PEGylated u...
Saved in:
Main Authors: | Robert J. Morlock, Deepan Dalal, Victoria Divino, Mitchell DeKoven, Stephanie D. Taylor, Atsuko Powers, Naina Barretto, Robert J. Holt, Brian LaMoreaux |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-11-01
|
Series: | Rheumatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40744-024-00723-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pegloticase and Methotrexate Cotherapy in Patients With Uncontrolled Gout With Prior Pegloticase Monotherapy Failure: Findings of an Open‐Label Trial
by: Orrin M. Troum, et al.
Published: (2025-01-01) -
The efficacy of a low-dose combination of febuxostat and benzbromarone versus each drug used alone for the treatment of gout
by: Caiyu Zheng, et al.
Published: (2025-02-01) -
Analysis of the efficacy of multidisciplinary integration based on 3D reconstruction technology for the treatment of gout stone
by: Shizhe Zhou, et al.
Published: (2025-02-01) -
Case Report: Intradural gout tophi without systemic gout symptoms
by: Peidong Qing, et al.
Published: (2025-02-01) -
Severe entheseal involvement in a patient with gout
by: Kunal Chandwar, et al.
Published: (2022-01-01)